Medtronic Defibrillator Lead Recall Attorneys
Medtronic Announces Clinical Trial for Neurostimulation Therapy
- E-mail this Article
- Print this Article
- Text Size: A A
Editor: Marc Jay Bern
Profession: Defective Medical Device Lawyer
Category: Medtronic News
Medtronic plans to initiate a prospective, multi-center, randomized U.S. clinical trial for the RestoreSensor neurostimulator that adapts therapy to the changing needs of chronic pain patients.
The RestoreSensor neurostimulator received CE Mark approval in Europe and is under investigational use in the United States.
The clinical trial will evaluate the benefits of the unique AdaptiveStim feature of the RestoreSensor device. Physicians at 10 U.S. medical centers will enroll patients in the study.
The first RetoreSensor study was performed by a doctor in Minneapolis.
[More]
Trackback Pings
TrackBack URL for this entry:
http://myblog.clarislaw.com/usa/mt-tb.cgi/3496